Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Kingdom of Saudi Arabia (KSA) has announced the public launch of Project CODE, an international development effort designed to address three of the biggest challenges confronting the Middle East today: healthcare, food security and homeland security.

Project CODE has the goal of acquiring 500 companies in the coming years to bring many of the world’s leading technologies (and technologists) to KSA. The project is being headed up by Mr Ali Al Rakaf and Professor Newton Howard from the University of Oxford, who have been entrusted by the government of Saudi Arabia to spend over $1,000,000,000 USD in the coming years to establish a new class of partnership between industry and academia, combining the efforts of several American medical and high-tech companies with many of the top academic and research institutions on the planet, including MIT, Johns Hopkins, Paris INSERM, the University of Oxford, George Washington University, the University of Michigan and the University of Southern California. 

Although Saudi Arabia boasts the 19th highest GDP in the world, the country is presently an oil-based economy and seeks diversification. Project CODE will have a significant impact in this area, serving to grow the private sector while establishing the region as the leading source of advanced medical and technical services in the Arab world.

With respect to healthcare, destinations such as the United Arab Emirates have long-established partnerships with leading American and English hospitals to provide their citizens with the best medical care in the world.  However, these services are very expensive and so are only available to the wealthy.  For those unable to afford such healthcare, there are few options. Project CODE intends to develop a more scalable healthcare model, with doctors, medical device manufacturers and research experts actively working together to adapt and miniaturize state-of-the-art medical technologies to provide more affordable and accessible healthcare for all, regardless of economic class or location.

To accomplish this, Project CODE will invest into technologies with the greatest potential impact. Neurological diseases, for example, account for the fastest-growing segment of healthcare expense in the developed world, with conditions such as Alzheimer’s Disease, Parkinson’s Disease, dementia and depression being among the most common.

Project CODE seeks to increase awareness about neurological disorders not only among doctors and caregivers, but also within the general population. The project plans to initiate a dementia awareness and prevention programme in KSA, which would be the very first programme of its kind within the Middle East. Using a novel and relatively inexpensive screening technology developed within the Oxford Computational Neuroscience lab at the Nuffield Department of Surgical Sciences and manufactured by Brain Sciences, Inc (BSI), this prevention programme will provide caregivers with the latest technology to detect neurodegenerative symptoms, as early as possible, to improve treatment outcomes for patient and caregiver alike.

Read the full story on LinkedIn.

Similar stories

New Cochrane evidence explores treatment options for chronic ear disease

Publication Research

A new Evidently Cochrane blog post for World Hearing Day summarises seven recent reviews on medical treatments for infection and inflammation of the middle ear.

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

Innovation Research

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.

Applications for Oxford-Wolfson-Marriott-Patel Scholarship now open

Awards and appointments Department Research

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.

Oxford University breakthrough on global COVID-19 vaccine

Coronavirus COVID-19 Research

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.